Sunshine Biopharma Inc.

SBFM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001402328

SEC filings (opens in a new tab)

No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.

Other share classesSBFMW

Q1 2023 vs. Q4 2022

How the institutions holding Sunshine Biopharma Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of SBFM: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	12	13	+1
Shares	407.6K	406.4K	−1.14K (−0.3%)
Value	$261.8K	$292.4K	+$30.6K (+11.7%)

New holders (2)

Institutions that held Sunshine Biopharma Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to SBFM in Q1 2023
Institution	Shares	Value	% of portfolio
Two Sigma Securities, LLC	25,303	$18.5K	0.00%
Morgan Stanley	26	$19	0.00%

Sold out (1)

Institutions that held Sunshine Biopharma Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of SBFM in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Bank of America Corp	13,872	$8.88K